Citra Borneo Utama Tbk. vs Tempo Scan Pacific Tbk. — how do they compare? Citra Borneo Utama Tbk. trades at Rp795 (market cap 2.47T, 58.6K 24h volume), while Tempo Scan Pacific Tbk. trades at Rp2,520 (market cap 11.18T, 613K 24h volume). The key difference: Tempo Scan Pacific Tbk. is far larger — about 4.5× Citra Borneo Utama Tbk.'s market cap, and Tempo Scan Pacific Tbk. is more actively traded (613K versus 58.6K). Which is the better fit depends on your goals.
| CBUT | TSPC | |
|---|---|---|
Market Cap | 2.47T | 11.18T |
Volume | 58.6K | 613K |
Lot | 586 | 6.13K |
Turnover | 46.6M | 1.54B |
Average Price | 795.15 | 2,511.52 |
Value | 46.6M | 1.54B |
Indicative Equilibrium Price | 795 | 2,520 |
Indicative Equilibrium Volume | 1 | 17 |
Trailing returns across standard periods
Latest headlines on both assets
PT Citra Borneo Utama Tbk (the “Company”) was established based on Notarial Deed No. 102 dated 14 March 2013 of Teguh Hendrawan, S.H., M.Kn. Notary in Pangkalan Bun. The Company commenced its commercial activities in August 2018.
Read more on CBUT →PT. Tempo Scan Pacific Tbk (the Company) was established in the Republic of Indonesia dated 20 May 1970, under its original name PT Scanchemie within the framework of the Domestic Capital Investment Law No. 6 year 1968, as amended by Law No. 12 year 1970, based on Notarial Deed No. 37 of Ridwan Suselo, S.H. The company is famous for such pharmaceutical products as Bodrex, Hemaviton and Neo-Rheumacyl.
Read more on TSPC →